STADA Arzneimittel Stock Price, News & Analysis (ETR:SAZ)

€86.22 -0.42 (-0.48 %)
(As of 02/21/2018 02:28 AM ET)
Previous Close€86.64
Today's Range€85.92 - €86.98
52-Week Range€53.41 - €90.24
Volume39,906 shs
Average Volume44,497 shs
Market Capitalization$5.40 billion
P/E Ratio56.72
Dividend Yield0.83%
BetaN/A

About STADA Arzneimittel (ETR:SAZ)

STADA Arzneimittel logoSTADA Arzneimittel Aktiengesellschaft engages in the development and marketing of active pharmaceutical ingredients for the health care and pharmaceutical markets worldwide. It operates through two segments, Generics and Branded Products. The Generics segment provides various generic active ingredients, including Tilidine naloxone for pain; Atorvastatin for elevated cholesterol levels; Pantoprazole for stomach ulcer/reflux; Diclofenac for pain/inflammation; and Enalapril for high blood pressure indications. The Branded Products segment offers APO-Go a Parkinson's medicine; Aqualor for rhinitis/sore throat; Grippostad a cold medicine; Snup for rhinitis; and Vitaprost for prostate disease indications, as well as Ladival a sun protection product. The company is also involved in the wholesale activities in the pharmaceutical market. It serves patients and consumers, doctors, pharmacies and pharmacy chains, hospitals, mail-order companies, buying groups, wholesalers, and other service providers in the health care market, as well as public or private health insurance organizations. STADA Arzneimittel Aktiengesellschaft was founded in 1895 and is headquartered in Bad Vilbel, Germany.

Receive SAZ News and Ratings via Email

Sign-up to receive the latest news and ratings for SAZ and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry N/A
Sub-IndustryN/A
SectorN/A
SymbolETR:SAZ
CUSIPN/A
Phone+49-6101-6030

Debt

Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A

Price-To-Earnings

Trailing P/E Ratio56.7236842105263
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A

Profitability

Trailing EPS€1.52
Net IncomeN/A
Net Margins3.48%
Return on Equity7.58%
Return on Assets2.27%

Miscellaneous

EmployeesN/A
Outstanding Shares62,260,000

STADA Arzneimittel (ETR:SAZ) Frequently Asked Questions

What is STADA Arzneimittel's stock symbol?

STADA Arzneimittel trades on the ETR under the ticker symbol "SAZ."

Where is STADA Arzneimittel's stock going? Where will STADA Arzneimittel's stock price be in 2018?

6 brokers have issued 12 month target prices for STADA Arzneimittel's stock. Their forecasts range from €66.00 to €89.00. On average, they expect STADA Arzneimittel's share price to reach €74.08 in the next twelve months. View Analyst Ratings for STADA Arzneimittel.

Who are some of STADA Arzneimittel's key competitors?

Who are STADA Arzneimittel's key executives?

STADA Arzneimittel's management team includes the folowing people:

  • Claudio Albrecht, Chairman of the Executive Board, Chief Executive Officer
  • Guenter von Au, Chairman of the Supervisory Board (Age 66)
  • Jens Steegers, Deputy Chairman of the Supervisory Board, Employee Representative (Age 37)
  • Mark Keatley, Chief Financial Officer, Member of the Executive Board
  • Barthold Piening, Chief Technical Operations Officer, Member of the Executive Board (Age 58)
  • Ralph Grobecker, Managing Director of OTC segment
  • Eric Cornut, Member of the Supervisory Board (Age 60)
  • Halil Duru, Member of the Supervisory Board, Employee Representative (Age 57)
  • Jan-Nicolas Garbe, Member of the Supervisory Board
  • Benjamin Kunstler, Member of the Supervisory Board

What is STADA Arzneimittel's stock price today?

One share of STADA Arzneimittel stock can currently be purchased for approximately €86.22.

How big of a company is STADA Arzneimittel?

STADA Arzneimittel has a market capitalization of $5.40 billion.

How can I contact STADA Arzneimittel?

STADA Arzneimittel's mailing address is Stadastrasse 2-18, BAD VILBEL, 61118, Germany. The company can be reached via phone at +49-6101-6030.


MarketBeat Community Rating for STADA Arzneimittel (SAZ)

Community Ranking:  1.6 out of 5 (star)
Outperform Votes:  47 (Vote Outperform)
Underperform Votes:  102 (Vote Underperform)
Total Votes:  149
MarketBeat's community ratings are surveys of what our community members think about STADA Arzneimittel and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

STADA Arzneimittel (ETR:SAZ) Analysts' Consensus Rating

  (How are Consensus Ratings Calculated?)
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: SellSellSellSell
Consensus Rating Score: 1.331.331.331.40
Ratings Breakdown: 4 Sell Rating(s)
2 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s)
4 Sell Rating(s)
2 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s)
4 Sell Rating(s)
2 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s)
3 Sell Rating(s)
2 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: €74.08€74.08€71.43€66.95

STADA Arzneimittel (ETR:SAZ) Consensus Price Target History

Price Target History for STADA Arzneimittel (ETR:SAZ)

STADA Arzneimittel (ETR:SAZ) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetDetails
12/26/2017Independent ResearchSet Price TargetNeutral€89.00View Rating Details
12/26/2017CommerzbankSet Price TargetSell€66.25View Rating Details
12/26/2017Nord/LBSet Price TargetSell€74.40View Rating Details
12/20/2017Warburg ResearchSet Price TargetSell€74.40View Rating Details
11/10/2017S&P GlobalSet Price TargetSell€74.40View Rating Details
7/11/2017Kepler Capital MarketsSet Price TargetNeutral€66.00View Rating Details
(Data available from 2/21/2016 forward)

Earnings

Earnings History for STADA Arzneimittel (ETR:SAZ)


No earnings announcements for this company have been tracked by MarketBeat.com

Estimates

STADA Arzneimittel (ETR:SAZ) Earnings Estimates

No earnings estimates for this company have been tracked by MarketBeat.com

Dividends

Dividend History for STADA Arzneimittel (ETR:SAZ)


No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for STADA Arzneimittel (ETR SAZ)

No insider trades for this company have been tracked by MarketBeat.com

Headlines

STADA Arzneimittel (ETR SAZ) News Headlines

Source:
DateHeadline
Stada Looks East in Expansion PushStada Looks East in Expansion Push
finance.yahoo.com - February 16 at 9:50 AM
STADA Arzneimittel Names Peter Goldschmidt CEO, Succeeding Claudio AlbrechtSTADA Arzneimittel Names Peter Goldschmidt CEO, Succeeding Claudio Albrecht
www.nasdaq.com - February 1 at 8:33 AM
STADA Arzneimittel AG (SAZ) Given Consensus Recommendation of "Sell" by BrokeragesSTADA Arzneimittel AG (SAZ) Given Consensus Recommendation of "Sell" by Brokerages
www.americanbankingnews.com - January 28 at 1:34 AM
STADA Arzneimittel AG (SAZ) Receives Consensus Recommendation of "Sell" from AnalystsSTADA Arzneimittel AG (SAZ) Receives Consensus Recommendation of "Sell" from Analysts
www.americanbankingnews.com - January 3 at 1:58 AM
Nord/LB Reiterates €74.40 Price Target for STADA Arzneimittel (SAZ)Nord/LB Reiterates €74.40 Price Target for STADA Arzneimittel (SAZ)
www.americanbankingnews.com - December 26 at 10:40 AM
STADA Arzneimittel (SAZ) Given a €66.25 Price Target at CommerzbankSTADA Arzneimittel (SAZ) Given a €66.25 Price Target at Commerzbank
www.americanbankingnews.com - December 26 at 8:34 AM
STADA Arzneimittel (SAZ) Given a €89.00 Price Target by Independent Research AnalystsSTADA Arzneimittel (SAZ) Given a €89.00 Price Target by Independent Research Analysts
www.americanbankingnews.com - December 26 at 7:36 AM
Commerzbank Analysts Give STADA Arzneimittel (SAZ) a €66.25 Price TargetCommerzbank Analysts Give STADA Arzneimittel (SAZ) a €66.25 Price Target
www.americanbankingnews.com - December 20 at 10:00 AM
STADA Arzneimittel (SAZ) PT Set at €74.40 by Nord/LBSTADA Arzneimittel (SAZ) PT Set at €74.40 by Nord/LB
www.americanbankingnews.com - December 20 at 10:00 AM
STADA Arzneimittel (SAZ) PT Set at €74.40 by Warburg ResearchSTADA Arzneimittel (SAZ) PT Set at €74.40 by Warburg Research
www.americanbankingnews.com - December 20 at 8:52 AM
STADA Arzneimittel (SAZ) Given a €89.00 Price Target at Independent ResearchSTADA Arzneimittel (SAZ) Given a €89.00 Price Target at Independent Research
www.americanbankingnews.com - December 20 at 8:02 AM
BRIEF-Stada Says Domination And Profit And Loss Transfer Agreement ConcludedBRIEF-Stada Says Domination And Profit And Loss Transfer Agreement Concluded
www.reuters.com - December 19 at 5:45 PM
STADA Arzneimittel Aktiengesellschaft (SAZ) Given Consensus Rating of "Sell" by BrokeragesSTADA Arzneimittel Aktiengesellschaft (SAZ) Given Consensus Rating of "Sell" by Brokerages
www.americanbankingnews.com - December 9 at 1:48 AM
STADA Arzneimittel Aktiengesellschaft (SAZ) Given a €74.40 Price Target at Nord/LBSTADA Arzneimittel Aktiengesellschaft (SAZ) Given a €74.40 Price Target at Nord/LB
www.americanbankingnews.com - November 29 at 10:48 AM
STADA Arzneimittel Aktiengesellschaft (SAZ) Given Average Rating of "Sell" by BrokeragesSTADA Arzneimittel Aktiengesellschaft (SAZ) Given Average Rating of "Sell" by Brokerages
www.americanbankingnews.com - November 14 at 1:50 AM
STADA Arzneimittel AG (SAZ) Given a €74.40 Price Target at Warburg ResearchSTADA Arzneimittel AG (SAZ) Given a €74.40 Price Target at Warburg Research
www.americanbankingnews.com - November 10 at 11:24 AM
STADA Arzneimittel AG (SAZ) Given a €74.40 Price Target by S&P Global AnalystsSTADA Arzneimittel AG (SAZ) Given a €74.40 Price Target by S&P Global Analysts
www.americanbankingnews.com - November 10 at 11:24 AM
Independent Research GmbH Analysts Give STADA Arzneimittel AG (SAZ) a €82.00 Price TargetIndependent Research GmbH Analysts Give STADA Arzneimittel AG (SAZ) a €82.00 Price Target
www.americanbankingnews.com - November 10 at 11:24 AM
STADA Arzneimittel Q3 Profit Rises; Says Well On Track To Achieve 2017 TargetsSTADA Arzneimittel Q3 Profit Rises; Says Well On Track To Achieve 2017 Targets
www.rttnews.com - November 9 at 3:16 PM
Stada Arzneimittel AG 2017 Q3 - Results - Earnings Call SlidesStada Arzneimittel AG 2017 Q3 - Results - Earnings Call Slides
seekingalpha.com - November 9 at 3:16 PM
STADA Arzneimittel AG (SAZ) Receives Average Recommendation of "Sell" from AnalystsSTADA Arzneimittel AG (SAZ) Receives Average Recommendation of "Sell" from Analysts
www.americanbankingnews.com - October 20 at 2:48 AM
Stada's CEO Says Top Line Growth Moved by New ProductsStada's CEO Says Top Line Growth Moved by New Products
finance.yahoo.com - October 6 at 8:42 AM
STADA Arzneimittel Appoints Claudio Albrecht As CEO, With Immediate EffectSTADA Arzneimittel Appoints Claudio Albrecht As CEO, With Immediate Effect
www.rttnews.com - September 28 at 2:39 AM
BRIEF-Stada says elects Guenter von Au as new chairmanBRIEF-Stada says elects Guenter von Au as new chairman
www.reuters.com - September 27 at 4:36 PM
STADA Arzneimittel Elects Günter Von Au As ChairmanSTADA Arzneimittel Elects Günter Von Au As Chairman
www.rttnews.com - September 27 at 4:36 PM
CVC Explores Options For $4 Bln Worth Alvogen: BloombergCVC Explores Options For $4 Bln Worth Alvogen: Bloomberg
www.rttnews.com - September 26 at 11:34 AM
Booming European Loan Market Tops 2016 on Chunky M&A DealsBooming European Loan Market Tops 2016 on Chunky M&A Deals
finance.yahoo.com - September 26 at 11:34 AM
STADA Arzneimittel AG (SAZ) Given Consensus Rating of "Sell" by BrokeragesSTADA Arzneimittel AG (SAZ) Given Consensus Rating of "Sell" by Brokerages
www.americanbankingnews.com - September 25 at 2:38 AM
DGAP-News: Nidda Healthcare Holding AG (deutsch)DGAP-News: Nidda Healthcare Holding AG (deutsch)
www.finanznachrichten.de - September 24 at 7:40 AM
[$$] Giant Bond Issued to Finance Stada Deal[$$] Giant Bond Issued to Finance Stada Deal
finance.yahoo.com - September 23 at 5:14 AM
[$$] Aggressive term in Stada bond sale causes outcry[$$] Aggressive term in Stada bond sale causes outcry
finance.yahoo.com - September 20 at 8:45 AM
STADA Arzneimittel AG (SAZ) Given a €76.00 Price Target by Independent Research GmbH AnalystsSTADA Arzneimittel AG (SAZ) Given a €76.00 Price Target by Independent Research GmbH Analysts
www.americanbankingnews.com - September 5 at 8:26 AM
Bain, Cinven give in to Elliotts demand for higher Stada buyoutBain, Cinven give in to Elliott's demand for higher Stada buyout
finance.yahoo.com - September 4 at 6:28 AM
[$$] Elliott seeks premium to back takeover of Stada[$$] Elliott seeks premium to back takeover of Stada
finance.yahoo.com - September 1 at 8:20 AM
STADA Arzneimittel AG (SAZ) Receives Average Recommendation of "Sell" from BrokeragesSTADA Arzneimittel AG (SAZ) Receives Average Recommendation of "Sell" from Brokerages
www.americanbankingnews.com - August 31 at 12:50 PM
Nord/LB Analysts Give STADA Arzneimittel AG (SAZ) a €65.53 Price TargetNord/LB Analysts Give STADA Arzneimittel AG (SAZ) a €65.53 Price Target
www.americanbankingnews.com - August 31 at 10:46 AM
Elliott demands at least 74.40 euros/share for its Stada stakeElliott demands at least 74.40 euros/share for its Stada stake
finance.yahoo.com - August 31 at 9:43 AM
STADA Arzneimittel AG (SAZ) Given a €66.25 Price Target by Warburg Research AnalystsSTADA Arzneimittel AG (SAZ) Given a €66.25 Price Target by Warburg Research Analysts
www.americanbankingnews.com - August 30 at 6:58 AM
STADA Arzneimittel AG (SAZ) PT Set at €76.00 by Independent Research GmbHSTADA Arzneimittel AG (SAZ) PT Set at €76.00 by Independent Research GmbH
www.americanbankingnews.com - August 29 at 7:58 AM
Commerzbank Ag Reiterates "€58.00" Price Target for STADA Arzneimittel AG (SAZ)Commerzbank Ag Reiterates "€58.00" Price Target for STADA Arzneimittel AG (SAZ)
www.americanbankingnews.com - August 21 at 11:02 PM
STADA Arzneimittel AG (SAZ) Given a €70.00 Price Target at Independent Research GmbHSTADA Arzneimittel AG (SAZ) Given a €70.00 Price Target at Independent Research GmbH
www.americanbankingnews.com - August 21 at 6:44 AM
[$$] Cinven and Bain secure Stada for ?4.1bn after second push[$$] Cinven and Bain secure Stada for ?4.1bn after second push
finance.yahoo.com - August 19 at 7:18 AM
Bain, Cinven Clinch Stada Purchase in $6.3 Billion DealBain, Cinven Clinch Stada Purchase in $6.3 Billion Deal
finance.yahoo.com - August 19 at 7:18 AM
How to Spend $1.6 Trillion? Start With an Obscure German DrugmakerHow to Spend $1.6 Trillion? Start With an Obscure German Drugmaker
finance.yahoo.com - August 16 at 4:14 PM
Elliott Makes Its $33 Billion Presence Felt in EuropeElliott Makes Its $33 Billion Presence Felt in Europe
finance.yahoo.com - August 16 at 4:14 PM
Longleaf Partners Comments on STADA ArzneimittelLongleaf Partners Comments on STADA Arzneimittel
finance.yahoo.com - July 26 at 7:06 AM
STADA Arzneimittel AG (ETR:SAZ) PT Set at €66.00 by Kepler Capital MarketsSTADA Arzneimittel AG (ETR:SAZ) PT Set at €66.00 by Kepler Capital Markets
www.americanbankingnews.com - July 11 at 10:43 AM
Stada Arzneimittal Shares Rise on Renewed Takeover Interest From Bain and CinvenStada Arzneimittal Shares Rise on Renewed Takeover Interest From Bain and Cinven
finance.yahoo.com - July 11 at 7:26 AM
Hedge Funds and a Prisoners DilemmaHedge Funds and a Prisoner's Dilemma
finance.yahoo.com - July 11 at 7:26 AM
Germanys Stada backs revised takeover bid from Bain and CinvenGermany's Stada backs revised takeover bid from Bain and Cinven
finance.yahoo.com - July 11 at 7:26 AM

SEC Filings

STADA Arzneimittel (ETR:SAZ) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Social activity is not available for this stock.

Financials

Financials are not available for this stock.

Chart

STADA Arzneimittel (ETR SAZ) Stock Chart for Wednesday, February, 21, 2018

Loading chart…

This page was last updated on 2/21/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.